PTC Therapeutics, Inc. (PTCT) ROE
- 2026-06-30: ROE 23.21%.
- 2026-03-31: ROE 103.47%.
- 2025-12-31: ROE -332.49%.
- 2025-09-30: ROE -482.62%.
Complete source-backed roe history.
- Available history
- 2011-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | 23.21% |
|---|
| 2026-03-31 | 103.47% |
|---|
| 2025-12-31 | -332.49% |
|---|
| 2025-09-30 | -482.62% |
|---|
| 2025-06-30 | -304.62% |
|---|
| 2025-03-31 | -320.22% |
|---|
| 2024-12-31 | 33.08% |
|---|
| 2024-09-30 | 42.98% |
|---|
| 2024-06-30 | 48.92% |
|---|
| 2024-03-31 | 64.80% |
|---|
| 2023-12-31 | 76.55% |
|---|
| 2023-09-30 | 95.66% |
|---|
| 2023-06-30 | 106.69% |
|---|
| 2023-03-31 | 124.85% |
|---|
| 2022-12-31 | 161.06% |
|---|
| 2022-09-30 | 234.19% |
|---|
| 2022-06-30 | 304.97% |
|---|
| 2022-03-31 | 576.26% |
|---|
| 2021-12-31 | -36432.61% |
|---|
| 2021-09-30 | -433.63% |
|---|
| 2021-06-30 | -198.93% |
|---|
| 2021-03-31 | -155.21% |
|---|
| 2020-12-31 | -90.91% |
|---|
| 2020-09-30 | -86.40% |
|---|
| 2020-06-30 | -75.42% |
|---|
| 2020-03-31 | -55.25% |
|---|
| 2019-12-31 | -42.33% |
|---|
| 2019-09-30 | -33.49% |
|---|
| 2019-06-30 | -43.63% |
|---|
| 2019-03-31 | -35.27% |
|---|
| 2018-12-31 | -36.52% |
|---|
| 2018-09-30 | -20.33% |
|---|
| 2018-06-30 | -22.91% |
|---|
| 2018-03-31 | -46.04% |
|---|
| 2017-12-31 | -50.50% |
|---|
| 2017-09-30 | -73.39% |
|---|
| 2017-06-30 | -63.92% |
|---|
| 2017-03-31 | -128.87% |
|---|
| 2016-12-31 | -118.84% |
|---|
| 2016-09-30 | -118.61% |
|---|
| 2016-06-30 | -105.25% |
|---|
| 2016-03-31 | -88.66% |
|---|
| 2015-12-31 | -75.42% |
|---|
| 2015-09-30 | -54.53% |
|---|
| 2015-06-30 | -52.63% |
|---|
| 2015-03-31 | -43.02% |
|---|
| 2014-12-31 | -31.41% |
|---|
| 2014-09-30 | -41.91% |
|---|
| 2014-06-30 | -27.49% |
|---|
| 2014-03-31 | -20.87% |
|---|
| 2013-12-31 | -37.77% |
|---|
| 2013-09-30 | -26.46% |
|---|
| 2013-06-30 | -28.01% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | -332.49% |
|---|
| 2024-12-31 | 33.08% |
|---|
| 2023-12-31 | 76.55% |
|---|
| 2022-12-31 | 161.06% |
|---|
| 2021-12-31 | -36432.61% |
|---|
| 2020-12-31 | -90.91% |
|---|
| 2019-12-31 | -42.33% |
|---|
| 2018-12-31 | -36.52% |
|---|
| 2017-12-31 | -50.50% |
|---|
| 2016-12-31 | -118.84% |
|---|
| 2015-12-31 | -75.42% |
|---|
| 2014-12-31 | -31.41% |
|---|
| 2013-12-31 | -37.77% |
|---|
| 2012-12-31 | 26.33% |
|---|
| 2011-12-31 | -12.95% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|